PATH vs XBIT
Uipath Inc (PATH) versus XBiotech Inc (XBIT) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
XBiotech Inc (XBIT) is a biotechnology company listed on US.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
XBIT does not have a complete income-statement cache yet.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. XBIT currently screens at market cap $83.8M.
Not investment advice. Open the PATH and XBIT stock pages for the full models.
Not investment advice.